Single‐Cell RNA Analysis Reveals Reduced Frequency and Activity of CXCR5 + Atypical Memory B Cells in Islet Xenotransplantation Treated With Clinically Applicable Immunosuppressants Including Belimumab
Xenotransplantation · 2025-09 · 32 (5)
DOI: 10.1111/xen.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 18.09.2025. Verfasst von Yuji Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, South Korea. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Islets of Langerhans Transplantation, Transplantation, Heterologous, Immunosuppressive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Technology R&D Project, the Korea Health Industry Development Institute, KHIDI.
Abstract (Originalsprache)
Background
Porcine‐to‐human islet xenotransplantation offers a promising solution to type 1 diabetes. This study investigates the use of Belimumab, a human monoclonal antibody that inhibits B cell activating factor (BAFF) as part of an immunosuppressive regimen in porcine‐to‐non‐human primate xenotransplantation.
Methods
Porcine islets were transplanted into Rhesus monkeys with an immunosuppressant regimen. Blood samples were collected from the monkeys pre‐ and post‐treatment, and single‐cell RNA sequencing was performed to investigate immune cell landscape changes, focusing on B cells.
Results
UMAP clustering of B cells identified five distinct subsets. Notably, Belimumab treatment significantly reduced the proportion of both CXCR5 + and CXCR5 − atypical memory B cells, which possess the potential to differentiate into antibody‐secreting cells. Furthermore, differentially expressed gene (DEG) analysis revealed a comprehensive functional impairment, along with significant downregulation of activation markers such as CD69 and CD83, across all B cell subsets.
Conclusions
Our study elucidates the mechanism of action of Belimumab in non‐human primate models, serving as preclinical subjects for B‐cell–targeted therapy research in a xenotransplantation context. Significantly, our data indicate that Belimumab not only reduces the proportion of antibody‐secreting atypical memory B cells but also induces functional impairment across all B cell subsets. Given the potential pathogenic roles of atypical memory B cells in autoimmunity and other related settings, their reduction by Belimumab could play a crucial role in regulating B‐cell–mediated immune responses in pig‐to‐non‐human primate pancreatic islet xenotransplantation. Thus, our findings highlight the prospective utility of Belimumab as a B cell suppressant in future clinical xenotransplantation applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, South Korea.
- Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, South Korea.
- Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea.
- Transplantation Research Institute, Seoul National University, Seoul, South Korea.
- PB Immune Therapeutics Inc, Seoul, South Korea.
- Xenotransplantation Research Center, College of Medicine, Seoul National University, Seoul, South Korea.
Förderung
- Korea Health Technology R&D Project
- the Korea Health Industry Development Institute
- KHIDI
- Ministry of Health & Welfare, Republic of Korea
- PB Immune Therapeutics (PBiT)
- Korea Health Industry Development Institute
Zitieren
APA
Lee, Y., Moon, J. H., Kim, H. J., Kim, D., Kim, Y. H., Kim, J. M., & Park, C. G. (2025). Single‐Cell RNA Analysis Reveals Reduced Frequency and Activity of CXCR5 + Atypical Memory B Cells in Islet Xenotransplantation Treated With Clinically Applicable Immunosuppressants Including Belimumab. Xenotransplantation, 32(5). https://doi.org/10.1111/xen.70076
Vancouver
Lee Y, Moon JH, Kim HJ, Kim D, Kim YH, Kim JM, et al. Single‐Cell RNA Analysis Reveals Reduced Frequency and Activity of CXCR5 + Atypical Memory B Cells in Islet Xenotransplantation Treated With Clinically Applicable Immunosuppressants Including Belimumab. Xenotransplantation. 2025;32(5). doi:10.1111/xen.70076
BibTeX
@article{Lee2025,
author = {Lee, Yuji and Moon, Ji Hwan and Kim, Hyun Je and Kim, Daesik and Kim, Yong-Hee and Kim, Jong-Min and Park, Chung-Gyu},
title = {Single‐Cell RNA Analysis Reveals Reduced Frequency and Activity of CXCR5 + Atypical Memory B Cells in Islet Xenotransplantation Treated With Clinically Applicable Immunosuppressants Including Belimumab},
journal = {Xenotransplantation},
year = {2025},
volume = {32},
number = {5},
doi = {10.1111/xen.70076}
}
EUVIMED